Progress towards the development of a HIV-1 gp41-directed vaccine
- PMID: 15078183
- DOI: 10.2174/1570162043484933
Progress towards the development of a HIV-1 gp41-directed vaccine
Abstract
The HIV-1 gp41 envelope glycoprotein mediates fusion of the viral and cellular membranes. The core of the gp41 ectodomain undergoes a receptor-triggered conformational transition forming a trimeric, alpha-helical coiled-coil structure. This trimer-of-hairpins species facilitates insertion of the viral envelope protein into the host cell membrane promoting viral entry. The prefusogenic conformation of gp41 is capable of stimulating a neutralizing antibody immune response and is therefore an attractive therapeutic target. Several broadly neutralizing HIV-1 monoclonal antibodies which bind to gp41 have been characterized and include 4E10, Z13 and 2F5. A conserved segment of gp41 (residues 661-684) has been identified as the epitope for the HIV-1 neutralizing antibody 2F5 (MAb 2F5). MAb 2F5 has attracted considerable attention because of the highly conserved recognition epitope and the ability to neutralize both laboratory-adapted and primary viral isolates. Antibodies which recognize the immunodominant regions of gp41 may provide protection against HIV infection if elicited at appropriate concentrations. Here we review the rational design, structure-activity relationships and conformational features of both linear and constrained peptide immunogens incorporating variants of both the 2F5 epitope and the gp41 ectodomain. This review describes a rational design approach combining structural characterization with traditional SAR to optimize MAb 2F5 antibody affinities of gp41-based peptide immunogens. The immunogens are shown to stimulate a high titer, peptide-specific immune response; however, the resulting antisera were incapable of viral neutralization. The implication of these findings with regard to structural and immunological considerations is discussed.
Similar articles
-
HIV-1 vaccine development: constrained peptide immunogens show improved binding to the anti-HIV-1 gp41 MAb.Biochemistry. 2003 Mar 25;42(11):3214-23. doi: 10.1021/bi026952u. Biochemistry. 2003. PMID: 12641452
-
Anti-human immunodeficiency virus type 1 (HIV-1) antibodies 2F5 and 4E10 require surprisingly few crucial residues in the membrane-proximal external region of glycoprotein gp41 to neutralize HIV-1.J Virol. 2005 Jan;79(2):1252-61. doi: 10.1128/JVI.79.2.1252-1261.2005. J Virol. 2005. PMID: 15613352 Free PMC article.
-
Interactions of HIV-1 antibodies 2F5 and 4E10 with a gp41 epitope prebound to host and viral membrane model systems.Chembiochem. 2009 Apr 17;10(6):1032-44. doi: 10.1002/cbic.200800609. Chembiochem. 2009. PMID: 19283693
-
The membrane-proximal external region of the human immunodeficiency virus type 1 envelope: dominant site of antibody neutralization and target for vaccine design.Microbiol Mol Biol Rev. 2008 Mar;72(1):54-84, table of contents. doi: 10.1128/MMBR.00020-07. Microbiol Mol Biol Rev. 2008. PMID: 18322034 Free PMC article. Review.
-
Antigp41 membrane proximal external region antibodies and the art of using the membrane for neutralization.Curr Opin HIV AIDS. 2017 May;12(3):250-256. doi: 10.1097/COH.0000000000000364. Curr Opin HIV AIDS. 2017. PMID: 28422789 Review.
Cited by
-
Immunisation with foamy virus Bet fusion proteins as novel strategy for HIV-1 epitope delivery.Immunol Res. 2013 May;56(1):61-72. doi: 10.1007/s12026-013-8387-x. Immunol Res. 2013. PMID: 23440699
-
Immunising with the transmembrane envelope proteins of different retroviruses including HIV-1: a comparative study.Hum Vaccin Immunother. 2013 Mar;9(3):462-70. doi: 10.4161/hv.23221. Epub 2012 Dec 18. Hum Vaccin Immunother. 2013. PMID: 23249763 Free PMC article. Review.
-
Antibodies neutralizing feline leukaemia virus (FeLV) in cats immunized with the transmembrane envelope protein p15E.Immunology. 2006 Feb;117(2):229-37. doi: 10.1111/j.1365-2567.2005.02291.x. Immunology. 2006. PMID: 16423059 Free PMC article.
-
Stoichiometry of murine leukemia virus envelope protein-mediated fusion and its neutralization.J Virol. 2006 Dec;80(24):11982-90. doi: 10.1128/JVI.01318-06. Epub 2006 Oct 11. J Virol. 2006. PMID: 17035325 Free PMC article.
-
Role of lipid structure in the humoral immune response in mice to covalent lipid-peptides from the membrane proximal region of HIV-1 gp41.Vaccine. 2009 Jul 23;27(34):4672-83. doi: 10.1016/j.vaccine.2009.05.059. Epub 2009 Jun 9. Vaccine. 2009. PMID: 19520200 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous